Preferred Label : 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid;

MeSH note : has anti-atherosclerotic activity;

MeSH synonym : bempedoic acid;

MeSH hyponym : ESP-55016;

Is substance : O;

UNII : 1EJ6Z6Q368;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3594378/fr/nilemdo-acide-bempedoique-dyslipidemie
2025
false
false
false
France
adult
risk
treatment outcome
insurance, health, reimbursement
bempedoic acid
nilemdo
Heart Disease Risk Factors
primary prevention
secondary prevention
cardiovascular diseases
Atherosclerotic Cardiovascular Disease
administration, oral
Product containing precisely bempedoic acid 180 milligram/1 each conventional release oral tablet (clinical drug)
evaluation of the transparency committee
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
hypercholesterolemia

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nilemdo
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
bempedoic acid
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
drug approval
europe
anticholesteremic agents
anticholesteremic agents
drug therapy, combination
hydroxymethylglutaryl-coa reductase inhibitors
Primary hypercholesterolaemia
hypercholesterolemia
mixed dyslipidemia
dyslipidemias
administration, oral
ATP citrate (pro-S)-Lyase
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dicarboxylic acids
fatty acids
dicarboxylic acids
fatty acids

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nustendi
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Ezetimibe
Ezetimibe
anticholesteremic agents
anticholesteremic agents
ATP citrate (pro-S)-Lyase
hypercholesterolemia
Primary hypercholesterolaemia
dyslipidemias
mixed dyslipidemia
adult
aged
administration, oral
bempedoic acid and ezetimibe
NPC1-Like Intracellular Cholesterol Transporter 1
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dicarboxylic acids
fatty acids
dicarboxylic acids
fatty acids

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.